Matches in Wikidata for { <http://www.wikidata.org/entity/Q36880037> ?p ?o ?g. }
- Q36880037 description "2016 nî lūn-bûn" @default.
- Q36880037 description "2016年の論文" @default.
- Q36880037 description "2016年論文" @default.
- Q36880037 description "2016年論文" @default.
- Q36880037 description "2016年論文" @default.
- Q36880037 description "2016年論文" @default.
- Q36880037 description "2016年論文" @default.
- Q36880037 description "2016年论文" @default.
- Q36880037 description "2016年论文" @default.
- Q36880037 description "2016年论文" @default.
- Q36880037 description "2016年论文" @default.
- Q36880037 description "2016年论文" @default.
- Q36880037 description "2016年论文" @default.
- Q36880037 description "2016년 논문" @default.
- Q36880037 description "article científic" @default.
- Q36880037 description "article scientific" @default.
- Q36880037 description "article scientifique publié en 2016" @default.
- Q36880037 description "articol științific" @default.
- Q36880037 description "articolo scientifico" @default.
- Q36880037 description "artigo científico (publicado na 2016)" @default.
- Q36880037 description "artigo científico (publicado na 2016)" @default.
- Q36880037 description "artigo científico" @default.
- Q36880037 description "artikel ilmiah" @default.
- Q36880037 description "artikull shkencor" @default.
- Q36880037 description "artikulong pang-agham" @default.
- Q36880037 description "artykuł naukowy" @default.
- Q36880037 description "artículo científico publicado en 2016" @default.
- Q36880037 description "artículu científicu espublizáu en 2016" @default.
- Q36880037 description "bilimsel makale" @default.
- Q36880037 description "bài báo khoa học" @default.
- Q36880037 description "mokslinis straipsnis" @default.
- Q36880037 description "naučni članak" @default.
- Q36880037 description "scienca artikolo" @default.
- Q36880037 description "scientific article published on 21 March 2016" @default.
- Q36880037 description "scientific article published on 21 March 2016" @default.
- Q36880037 description "scientific article published on 21 March 2016" @default.
- Q36880037 description "teaduslik artikkel" @default.
- Q36880037 description "tieteellinen artikkeli" @default.
- Q36880037 description "tudományos cikk" @default.
- Q36880037 description "vedecký článok" @default.
- Q36880037 description "vetenskaplig artikel" @default.
- Q36880037 description "videnskabelig artikel (udgivet 2016)" @default.
- Q36880037 description "vitenskapelig artikkel" @default.
- Q36880037 description "vitskapeleg artikkel" @default.
- Q36880037 description "vědecký článek" @default.
- Q36880037 description "wetenschappelijk artikel" @default.
- Q36880037 description "wissenschaftlicher Artikel" @default.
- Q36880037 description "επιστημονικό άρθρο" @default.
- Q36880037 description "мақолаи илмӣ" @default.
- Q36880037 description "мақолаи илмӣ" @default.
- Q36880037 description "наукова стаття, опублікована в березні 2016" @default.
- Q36880037 description "научна статия" @default.
- Q36880037 description "научная статья" @default.
- Q36880037 description "научни чланак" @default.
- Q36880037 description "научни чланак" @default.
- Q36880037 description "գիտական հոդված" @default.
- Q36880037 description "מאמר מדעי" @default.
- Q36880037 description "سائنسی مضمون" @default.
- Q36880037 description "مقالة علمية نشرت في 21 مارس 2016" @default.
- Q36880037 description "مقالهٔ علمی" @default.
- Q36880037 description "২১ মার্চ ২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q36880037 description "บทความทางวิทยาศาสตร์" @default.
- Q36880037 description "სამეცნიერო სტატია" @default.
- Q36880037 name "Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer" @default.
- Q36880037 name "Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer" @default.
- Q36880037 name "Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer" @default.
- Q36880037 type Item @default.
- Q36880037 label "Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer" @default.
- Q36880037 label "Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer" @default.
- Q36880037 label "Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer" @default.
- Q36880037 prefLabel "Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer" @default.
- Q36880037 prefLabel "Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer" @default.
- Q36880037 prefLabel "Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer" @default.
- Q36880037 P1433 Q36880037-163F67D4-804F-49AC-AC33-142FBA49E1B1 @default.
- Q36880037 P1476 Q36880037-A96F5355-E3C0-452C-A55E-5CEA3F5DA520 @default.
- Q36880037 P2093 Q36880037-0CD6ECFB-949E-4220-AD39-09D74F2E62E9 @default.
- Q36880037 P2093 Q36880037-1140F837-F101-4586-BE7F-A6D5EF958FCD @default.
- Q36880037 P2093 Q36880037-122BCC00-890F-4C05-AF46-5EBB7150B7E5 @default.
- Q36880037 P2093 Q36880037-1B0E4559-1F10-4CD3-8EDD-A3101D9162F2 @default.
- Q36880037 P2093 Q36880037-2E68C562-7354-4C54-9958-877D8D171219 @default.
- Q36880037 P2093 Q36880037-44BF7BEA-CBB5-4AD5-A76C-786475A9CACC @default.
- Q36880037 P2093 Q36880037-5C1A2B56-B244-4F2D-B822-4EB471C2259D @default.
- Q36880037 P2093 Q36880037-7DC2828D-354C-4D82-AEE9-65B3F1EE2142 @default.
- Q36880037 P2093 Q36880037-7F677D4B-37B7-4310-93E1-6AD720BC44B5 @default.
- Q36880037 P2093 Q36880037-A5A6F524-F509-4516-A6A4-654574AF1904 @default.
- Q36880037 P2093 Q36880037-EEDABBE1-BB27-4E92-854B-34CF21675A76 @default.
- Q36880037 P2093 Q36880037-F6B60AE1-D778-4847-97C6-3CDB316ADDB7 @default.
- Q36880037 P2860 Q36880037-001EB094-265A-4419-B8BD-65331ED43A56 @default.
- Q36880037 P2860 Q36880037-16BFF79E-D2DD-4852-B78C-C3ACDCCF3E4A @default.
- Q36880037 P2860 Q36880037-1C2C3322-F821-4D52-95B4-982E5AC402A8 @default.
- Q36880037 P2860 Q36880037-2D1FF451-C86A-42D7-B4B0-6C88DF2D70DE @default.
- Q36880037 P2860 Q36880037-3AE45843-E369-409B-804F-DD3C050C5295 @default.
- Q36880037 P2860 Q36880037-64DBF1F1-ED9F-4B13-9198-3B925B20E873 @default.
- Q36880037 P2860 Q36880037-6F0CA2DF-8A22-4B3D-98B5-08004138824A @default.
- Q36880037 P2860 Q36880037-6FCB22DA-2BEE-4B52-965A-5DE8A06EC762 @default.
- Q36880037 P2860 Q36880037-7C90B578-CD35-4985-8F22-2B845B322453 @default.
- Q36880037 P2860 Q36880037-83C35193-5E38-49C7-AD2B-C22C5C4E88DD @default.
- Q36880037 P2860 Q36880037-8758C195-403B-42BE-A5AA-4787E2060E98 @default.
- Q36880037 P2860 Q36880037-8EA7492A-DA4A-42CE-8199-CFCB4DBDB762 @default.
- Q36880037 P2860 Q36880037-91915800-1810-4AB9-9A8F-F0BF3E312C2C @default.